Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China · Delayed Price · Currency is CNY

26.86

+0.30 (1.13%)

Sep 30, 2026, 3:00 PM CST

Market Cap	4.12B -34.0%
Revenue (ttm)	3.18B -3.7%
Net Income	316.43M -7.9%
EPS	2.08 -8.5%
Shares Out	153.40M
PE Ratio	12.90
Forward PE	n/a
Dividend	0.90 (3.35%)
Ex-Dividend Date	Apr 28, 2026

Volume	1,216,100
Open	26.56
Previous Close	26.56
Day's Range	26.55 - 26.90
52-Week Range	24.68 - 40.73
Beta	0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1637

Employees 2,257

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600976

Full Company Profile

Financial Performance

In 2025, SHA:600976's revenue was 3.37 billion, a decrease of -3.85% compared to the previous year's 3.50 billion. Earnings were 359.84 million, a decrease of -0.65%.

Financial Statements